The Evolution of Insulin and How it Informs Therapy and Treatment Choices.

Hirsch, Irl B; Juneja, Rattan; Beals, John M; Antalis, Caryl J; Wright, Eugene E

Hirsch, Irl B; Juneja, Rattan; Beals, John M; Antalis, Caryl J; Wright, Eugene E.

Afiliación

Hirsch IB; University of Washington Diabetes Institute, Seattle, Washington.
Juneja R; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Beals JM; Eli Lilly and Company, Lilly Biotechnology Center, San Diego, California.
Antalis CJ; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Wright EE; Charlotte Area Health Education Center, Charlotte, North Carolina.

Endocr Rev ; 41(5)2020 10 01.

Article en En | MEDLINE | ID: mdl-32396624

Asunto(s)

Diabetes Mellitus/tratamiento farmacológico; Hipoglucemiantes/farmacocinética; Insulinas/metabolismo; Insulinas/farmacocinética; Humanos; Insulinas/análisis

Palabras clave

insulin; long-acting; pharmacodynamics; pharmacokinetics; rapid-acting

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus / Insulinas / Hipoglucemiantes Límite: Humans Idioma: En Revista: Endocr Rev Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google